Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain

Brain Pathology

Volumn 19, Issue 4, 2009, Pages 612-622

  Wilhelmus, Micha M M ^a   Grunberg, Sentini C S ^a   Bol, John G J M ^a   Van Dam, Anne Marie ^a   Hoozemans, Jeroen J M ^a   Rozemuller, Annemieke J M ^a   Drukarch, Benjamin ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Cross links; Neurofibrillary tangles; Senile plaques; Transglutaminase

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CEREBRAL AMYLOID ANGIOPATHY; CROSS-LINKING REAGENTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOCORTEX; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; PLAQUE, AMYLOID; TAU PROTEINS; TRANSGLUTAMINASES;

EID: 69949125668     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00197.x     Document Type: Article

References (58)

1. Aeschlimann D, Thomazy V (2000) Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 41 : 1 27.
2. Akimov SS, Belkin AM (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98 : 1567 1576.
3. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM et al (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273 : 12817 12826.
4. Baumgartner W, Weth A (2007) Transglutaminase 1 stabilizes beta-actin in endothelial cells correlating with a stabilization of intercellular junctions. J Vasc Res 3 : 234 240.
5. Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G (2002) Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease. Neurobiol Dis 11 : 106 110.
6. Breve JJ, Drukarch B, van Strien M, van Dam AM (2008) Validated sandwich ELISA for the quantification of tissue transglutaminase in tissue homogenates and cell lysates of multiple species. J Immunol Methods 332 : 142 150.
7. Chakravarty R, Rong XH, Rice RH (1990) Phorbol ester-stimulated phosphorylation of keratinocyte transglutaminase in the membrane anchorage region. Biochem J 271 : 25 30.
8. Chen JS, Mehta K (1999) Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol 31 : 817 836.
9. Citron BA, Suo Z, SantaCruz K, Davies PJ, Qin F, Festoff BW (2002) Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem Int 40 : 69 78.
10. Dudek SM, Johnson GV (1993) Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J Neurochem 61 : 1159 1162.
11. Dudek SM, Johnson GV (1994) Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Brain Res 651 : 129 133.
12. Duff K, Planel E (2005) Untangling memory deficits. Nat Med 11 : 826 827.
13. Eckert RL, Sturniolo MT, Broome AM, Ruse M, Rorke EA (2005) Transglutaminase function in epidermis. J Invest Dermatol 124 : 481 492.
14. Esposito C, Caputo I (2005) Mammalian transglutaminases: identification of substrates as a key to physiological function and physiopathological relevance. FEBS J 272 : 615 631.
15. Fesus L (1993) Biochemical events in naturally occurring forms of cell death. FEBS Lett 328 : 1 5.
16. Fonte V, Kapulkin V, Taft A, Fluet A, Friedman D, Link CD (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci USA 99 : 9439 9444.
17. Gamblin TC, Berry RW, Binder LI (2003) Modeling tau polymerization in vitro: a review and synthesis. Biochemistry 42 : 15009 15017.
18. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120 : 885 890.
19. Greenberg CS, Birckbichler PJ, Rice RH (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5 : 3071 3077.
20. Halverson RA, Lewis J, Frausto S, Hutton M, Muma NA (2005) Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice. J Neurosci 25 : 1226 1233.
21. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS (1999) Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J 13 : 1787 1795.
22. Hasegawa M, Crowther RA, Jakes R, Goedert M (1997) Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J Biol Chem 272 : 33118 33124.
23. Huang X, Atwood CS, Moir RD, Hartshorn MA, Vonsattel JP, Tanzi RE, Bush AI (1997) Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors. J Biol Chem 272 : 26464 26470.
24. Johnson GV, Cox TM, Lockhart JP, Zinnerman MD, Miller ML, Powers RE (1997) Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res 751 : 323 329.
25. Johnson TS, El-Koraie AF, Skill NJ, Baddour NM, El Nahas AM, Njloma M et al (2003) Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 14 : 2052 2062.
26. Kim SY, Grant P, Lee JH, Pant HC, Steinert PM (1999) Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J Biol Chem 274 : 30715 30721.
27. Konno T, Morii T, Hirata A, Sato S, Oiki S, Ikura K (2005) Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking. Biochemistry 44 : 2072 2079.
28. Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251 : 675 678.
29. Lesort M, Tucholski J, Miller ML, Johnson GV (2000) Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol 61 : 439 463.
30. Lorand L, Conrad SM (1984) Transglutaminases. Mol Cell Biochem 58 : 9 35.
31. Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4 : 140 156.
32. Magrane J, Smith RC, Walsh K, Querfurth HW (2004) Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons. J Neurosci 24 : 1700 1706.
33. McCarron MO, Nicoll JA, Stewart J, Cole GM, Yang F, Ironside JW et al (2000) Amyloid beta-protein length and cerebral amyloid angiopathy-related haemorrhage. Neuroreport 11 : 937 940.
34. Miller ML, Johnson GV (1995) Transglutaminase cross-linking of the tau protein. J Neurochem 65 : 1760 1770.
35. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 : 479 486.
36. Muma NA (2007) Transglutaminase is linked to neurodegenerative diseases. J Neuropathol Exp Neurol 66 : 258 263.
37. Nemes Z, Fesus L, Egerhazi A, Keszthelyi A, Degrell IM (2001) N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol Aging 22 : 403 406.
38. Norlund MA, Lee JM, Zainelli GM, Muma NA (1999) Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease. Brain Res 851 : 154 163.
39. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6 : 487 498.
40. Selkoe DJ (1997) Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275 : 630 631.
41. Selkoe DJ (2000) The origins of Alzheimer disease: a is for amyloid. JAMA 283 : 1615 1617.
42. Singer SM, Zainelli GM, Norlund MA, Lee JM, Muma NA (2002) Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease. Neurochem Int 40 : 17 30.
43. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90 : 1977 1981.
44. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M et al (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90 : 8098 8102.
45. Tucholski J, Kuret J, Johnson GV (1999) Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J Neurochem 73 : 1871 1880.
46. Verbeek MM, Eikelenboom P, de Waal RM (1997) Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J Neuropathol Exp Neurol 56 : 751 761.
47. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A et al (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274 : 25945 25952.
48. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M et al (2003) Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 115 : 851 862.
49. Webster S, Bonnell B, Rogers J (1997) Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide. Am J Pathol 150 : 1531 1536.
50. Webster S, Bradt B, Rogers J, Cooper N (1997) Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide. J Neurochem 69 : 388 398.
51. Wilhelmus MM, Otte-Holler I, Davis J, Van Nostrand WE, de Waal RM, Verbeek MM (2005) Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. J Neurosci 25 : 3621 3627.
52. Wilhelmus MM, Boelens WC, Otte-Holler I, Kamps B, de Waal RM, Verbeek MM (2006) Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res 1089 : 67 78.
53. Wilhelmus MM, Boelens WC, Otte-Holler I, Kamps B, Kusters B, Maat-Schieman ML et al (2006) Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity. Acta Neuropathol (Berl) 111 : 139 149.
54. Wilhelmus MM, Otte-Holler I, Wesseling P, de Waal RM, Boelens WC, Verbeek MM (2006) Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol Appl Neurobiol 32 : 119 130.
55. Wilhelmus MM, de Waal RM, Verbeek MM (2007) Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease. Mol Neurobiol 35 : 203 216.
56. Wilhelmus MM, Otte-Holler I, van Triel JJ, Veerhuis R, Maat-Schieman ML, Bu G et al (2007) Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. Am J Pathol 171 : 1989 1999.
57. Wilhelmus MM, van Dam AM, Drukarch B (2008) Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol 585 : 464 472.
58. Zhang W, Johnson BR, Suri DE, Martinez J, Bjornsson TD (1998) Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques. Acta Neuropathol 96 : 395 400.